2024/09/21 by Teixeira, Mónica, Aguiar, Cristina, Pina, Paulo +3
#Minimal clinically important difference #ROE #Rhinoplasty #SNOT-22 #Septoplasty
paper · doi:10.34631/sporl.2079
Objectives: We aim to evaluate patient functional and aesthetical satisfaction 1 year after rhinoseptoplasty and to determine the minimum clinically important difference (MCID) of SNOT-22 and ROE scores. Study design: A 1-year prospective study of adult patients undergoing rhinoseptoplasty in CHVNG/E was conducted. SNOT-22 and ROE scores were assessed preoperatively and 1 year after surgery. Results: We included 44 patients. 79.5% of our sample reported an improvement in quality-of-life regarding the functional outcome and 81.8% regarding the aesthetical outcome. The MCID of SNOT-22 score was 5 points, whilst the MCID of ROE score was 13.7 points. The mean change in ROE score was significantly lower among patients undergoing revision rhinoplasty (25.0 vs 51.4)(p=0.04). Conclusions: Rhinoseptoplasty improved quality-of-life in most patients. The history of previous rhinoseptoplasty was the only predictor of lower postoperative satisfaction.